Analysis of prescription regularity of traditional Chinese medicine for colorectal cancer based on data mining

Xiangjun Qi(Guangzhou University of Chinese Medicine), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Hanrui Chen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Meng-Yi Cai(Guangzhou University of Chinese Medicine), Zhuang-Zhong Chen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Pei-Xin Li(Guangzhou University of Chinese Medicine), Guoming Chen(Guangzhou University of Chinese Medicine), Jiahao Mo(Guangzhou University of Chinese Medicine), Xinrong Chen(Guangzhou University of Chinese Medicine), Wanning Lan(Guangzhou University of Chinese Medicine)
China Journal of Chinese Materia Medica
August 1, 2021
10.19540/j.cnki.cjcmm.20201127.501
Cited by 5

Related Papers

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants
|Redox Biology|2024|193
Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma
|Chinese Medicine|2021|95
Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
|Phytotherapy Research|2019|64
Negative association of C-reactive protein-albumin-lymphocyte index (CALLY index) with all-cause and cause-specific mortality in patients with cancer: results from NHANES 1999–2018
|BMC Cancer|2024|45